These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34896929)

  • 41. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K
    J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson's disease dementia.
    Gratwicke J; Oswal A; Akram H; Jahanshahi M; Hariz M; Zrinzo L; Foltynie T; Litvak V
    Neuroimage; 2020 Nov; 221():117184. PubMed ID: 32711059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy.
    Gang M; Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Hasegawa T; Aoki M; Takeda A; Mori E; Suzuki K
    Mov Disord; 2020 May; 35(5):825-832. PubMed ID: 31971293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease.
    Blasberg F; Wojtecki L; Elben S; Slotty PJ; Vesper J; Schnitzler A; Groiss SJ
    Neuromodulation; 2018 Aug; 21(6):541-547. PubMed ID: 29532560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease.
    Guttuso T; Sirica D; Tosun D; Zivadinov R; Pasternak O; Weintraub D; Baglio F; Bergsland N
    Mov Disord; 2022 Mar; 37(3):490-501. PubMed ID: 34936139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does Quantitative Electroencephalography Refine Preoperative Cognitive Assessment in Parkinson's Disease Patients Treated with Deep Brain Stimulation? A Follow-Up Study.
    Saleh C; Meyer A; Chaturvedi M; Beltrani S; Gschwandtner U; Fuhr P
    Dement Geriatr Cogn Disord; 2021; 50(4):349-356. PubMed ID: 34569496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anatomical predictors of cognitive decline after subthalamic stimulation in Parkinson's disease.
    Planche V; Munsch F; Pereira B; de Schlichting E; Vidal T; Coste J; Morand D; de Chazeron I; Derost P; Debilly B; Llorca PM; Lemaire JJ; Marques A; Durif F
    Brain Struct Funct; 2018 Sep; 223(7):3063-3072. PubMed ID: 29736590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease.
    Asahi T; Nakamichi N; Takaiwa A; Kashiwazaki D; Koh M; Dougu N; Takashima S; Tanaka K; Kuroda S
    Neurol Med Chir (Tokyo); 2014; 54(7):529-36. PubMed ID: 24872253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting Neurocognitive Change after Bilateral Deep Brain Stimulation of Subthalamic Nucleus for Parkinson's Disease.
    Yakufujiang M; Higuchi Y; Aoyagi K; Yamamoto T; Sakurai T; Abe M; Okahara Y; Izumi M; Nagano O; Yamanaka Y; Hirano S; Shiina A; Murata A; Iwadate Y
    World Neurosurg; 2021 Mar; 147():e428-e436. PubMed ID: 33359524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.
    You Z; Wu YY; Wu R; Xu ZX; Wu X; Wang XP
    CNS Neurosci Ther; 2020 Sep; 26(9):972-980. PubMed ID: 32436660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.
    Rong S; Li Y; Li B; Nie K; Zhang P; Cai T; Mei M; Wang L; Zhang Y
    Quant Imaging Med Surg; 2021 Apr; 11(4):1554-1566. PubMed ID: 33816191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Nucleus Basalis of Meynert and Its Role in Deep Brain Stimulation for Cognitive Disorders: A Historical Perspective.
    Koulousakis P; Andrade P; Visser-Vandewalle V; Sesia T
    J Alzheimers Dis; 2019; 69(4):905-919. PubMed ID: 31104014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yakufujiang M; Higuchi Y; Aoyagi K; Yamamoto T; Abe M; Okahara Y; Izumi M; Nagano O; Yamanaka Y; Hirano S; Shiina A; Murata A; Iwadate Y
    Acta Neurochir (Wien); 2019 Oct; 161(10):2049-2058. PubMed ID: 31278598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.
    Liu Y; Wu L; Yang C; Xian W; Zheng Y; Zhang C; Hong G; Jiang L; Yang Z; Pei Z; Liu J; Chen L
    J Neurol Sci; 2020 Nov; 418():117121. PubMed ID: 32950863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between surgical characteristics and cognitive decline following deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Mulders AEP; Temel Y; Tonge M; Schaper FLWVJ; van Kranen-Mastenbroek V; Ackermans L; Kubben P; Janssen MLF; Duits A
    Clin Neurol Neurosurg; 2021 Jan; 200():106341. PubMed ID: 33160716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.